DMPK

DMPK

    • Articles

      Pharmaceutical Innovation in the 21st Century


      02/2011 - Clin Pharmacol Ther.

      The first decade of the 21st century was a challenging period for the pharma sector and could prove to be a turning point in the evolution of the industry. We examine drug development performance metrics for new product approvals during 2000–2009 and compare them with those of the prior two decades.

      Read more
    • Friday 18 May   Calendar
    • 03/21/2011 - JEVTANA® (Cabazitaxel) Approved By European Commission For Treatment Of Advanced Second-Line Prostate Cancer

  • Testimonials

    • Testimonial from Dr. Xavier Boulenc on ADME

Polls

Would you be interested in subcontracting your DDI study to Aureus ?